NCBI Bookshelfopen access
Vorasidenib (Voranigo): Therapeutic area: Astrocytoma or oligodendroglioma, IDH1 or IDH2 mutation: Reimbursement Review
information security management
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 202836
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.